Alps Advisors Inc Organogenesis Holdings Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $16,296 - $33,371	-5,190 Reduced 6.78%	71,410 $231,000
Q2 2022 Aug 11, 2022	SELL	$4.74 - $8.15 $264,217 - $454,297	-55,742 Reduced 42.12%	76,600 $374,000
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $271,701 - $401,882	-41,994 Reduced 24.09%	132,342 $1.01 Million
Q4 2021 Feb 09, 2022	SELL	$9.02 - $13.5 $74,099 - $110,902	-8,215 Reduced 4.5%	174,336 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $201,111 - $252,013	14,669 Added 8.74%	182,551 $2.6 Million
Q2 2021 Aug 11, 2021	BUY	$14.92 - $23.23 $2.5 Million - $3.9 Million	167,882 New	167,882 $2.79 Million

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $462M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.